![Michael Bailey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bailey
Verkställande Direktör på
AVEO PHARMACEUTICALS, INC.
Förmögenhet: 467 640 $ per 2026-05-31
Profil
Michael P.
Bailey is currently President, Chief Executive Officer & Director at AVEO Pharmaceuticals, Inc. since 2010.
He is Chairman at IMV, Inc. since 2022 and Director at Verastem, Inc. starting in 2026.
Formerly, Mr. Bailey was a Member of Global Commercial Partnership Teams at Genentech, Inc., Senior Vice President-Commercial Operations at ImClone LLC from 1999 to 2008, and Chief Commercial Officer & Senior Vice President at Synta Pharmaceuticals Corp.
from 2008 to 2010.
Education includes undergraduate studies at St. Lawrence University and an MBA from Mendoza College of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VERASTEM, INC. 0,18 % | 2026-05-21 | 108 000 ( 0,18 % ) | 467 640 $ | 2026-05-31 |
Aktiva positioner av Michael Bailey
| Företag | Position | Start |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Verkställande Direktör | 2015-01-06 |
| IMV INC. | Ordförande | 2022-05-01 |
| VERASTEM, INC. | Direktör/Styrelseledamot | 2026-05-26 |
Tidigare kända positioner av Michael Bailey
| Företag | Position | Slut |
|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Företagsledare/Principal | 2010-09-07 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Företagsledare/Principal | 2008-08-01 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | - |
Utbildning av Michael Bailey
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
60
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Mendoza College of Business
 Mendoza College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
